We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+7.58%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$2.41B
AUM Growth
-$3.75B
Cap. Flow
-$4.09B
Cap. Flow %
-169.35%
Top 10 Hldgs %
31.78%
Holding
6,989
New
537
Increased
1,703
Reduced
3,620
Closed
686

Sector Composition

Rank Sector Weight
1 Technology 21.71%
2 Healthcare 7.7%
3 Consumer Discretionary 6.83%
4 Financials 6.52%
5 Industrials 4.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SVFA
5801
DELISTED
SVF Investment Corp. Class A Ordinary Shares
SVFA
$1K ﹤0.01%
+112
New +$1.12K
ARCKU
5802
DELISTED
Arbor Rapha Capital Bioholdings Corp. I Units
ARCKU
$1K ﹤0.01%
+99
New +$1.02K
AEACU
5803
DELISTED
Authentic Equity Acquisition Corp. Unit
AEACU
$1K ﹤0.01%
88
VIVE
5804
DELISTED
VIVEVE MED INC
VIVE
$1K ﹤0.01%
2,514
-193
-7% -$97
DLCAU
5805
DELISTED
Deep Lake Capital Acquisition Corp. Unit
DLCAU
$1K ﹤0.01%
106
FCAX
5806
DELISTED
Fortress Capital Acquisition Corp.
FCAX
$1K ﹤0.01%
132
-320
-71% -$3.21K
EPHYU
5807
DELISTED
Epiphany Technology Acquisition Corp. Unit
EPHYU
$1K ﹤0.01%
68
+2
+3% +$20
PACXU
5808
DELISTED
Pioneer Merger Corp. Unit
PACXU
$1K ﹤0.01%
111
LJAQU
5809
DELISTED
LightJump Acquisition Corporation Unit
LJAQU
$1K ﹤0.01%
58
EWEB
5810
DELISTED
Global X Emerging Markets Internet & E-commerce ETF
EWEB
$1K ﹤0.01%
24
GBL
5811
DELISTED
GAMCO Investors, Inc.
GBL
$1K ﹤0.01%
56
-661
-92% -$10.8K
PBLA
5812
DELISTED
Panbela Therapeutics, Inc. Common Stock
PBLA
$1K ﹤0.01%
1
BXRX
5813
DELISTED
Baudax Bio, Inc. Common Stock
BXRX
$1K ﹤0.01%
301
+137
+84% +$820
KACLU
5814
DELISTED
Kairous Acquisition Corp. Limited Unit
KACLU
$1K ﹤0.01%
68
PUCKU
5815
DELISTED
Goal Acquisitions Corp. Unit
PUCKU
$1K ﹤0.01%
98
AIBBU
5816
DELISTED
AIB Acquisition Corp Unit
AIBBU
$1K ﹤0.01%
99
MBTCU
5817
DELISTED
Nocturne Acquisition Corporation Unit
MBTCU
$1K ﹤0.01%
119
RCACU
5818
DELISTED
Revelstone Capital Acquisition Corp. Unit
RCACU
$1K ﹤0.01%
120
OPA.U
5819
DELISTED
Magnum Opus Acquisition Limited Units, each consisting of one Class A ordinary share and one-half redeemable warrant
OPA.U
$1K ﹤0.01%
100
NBO
5820
DELISTED
Neuberger Berman New York Municipal Fund Inc.
NBO
$1K ﹤0.01%
100
-100
-50% -$943
PTOCU
5821
DELISTED
Pine TechnologYES Acquisition Corp. Unit
PTOCU
$1K ﹤0.01%
74
RACY
5822
DELISTED
Relativity Acquisition Corp. Class A Common Stock
RACY
$1K ﹤0.01%
+90
New +$925
NTP
5823
DELISTED
Nam Tai Property Inc.
NTP
$1K ﹤0.01%
389
-247
-39% -$635
TIO
5824
DELISTED
Tingo Group, Inc. Common Stock
TIO
$1K ﹤0.01%
1,024
-8,714
-89% -$7.33K
PMGMU
5825
DELISTED
Priveterra Acquisition Corp. II Unit
PMGMU
$1K ﹤0.01%
98

Similar funds

Tower Research Capital (TRC)'s Q4 2022 Portfolio in Review

As of Q4 2022, Tower Research Capital (TRC) held 6,989 positions worth $2.41B, down 61% from $6.16B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Tower Research Capital (TRC) withdrew a net $4.09B in Q4 2022, closing 686 positions and reducing 3,620 holdings. Its most notable exit was Vanguard Russell 2000 Value ETF, an estimated $4.46M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Semiconductor ETF worth $9.33M.

  • Tower Research Capital (TRC)'s largest Q4 2022 buy was iShares Semiconductor ETF: 80,454 shares worth $9.33M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q4 2022, an estimated $145M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2022 reduction was Apple, cutting an estimated $322M.
  • Tower Research Capital (TRC) fully exited Vanguard Russell 2000 Value ETF in Q4 2022, selling an estimated $4.46M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 32% of its $2.41B portfolio in Q4 2022.
  • Tower Research Capital (TRC) opened 537 new positions and closed 686 in Q4 2022.
  • Tower Research Capital (TRC)'s portfolio value fell 61% quarter-over-quarter to $2.41B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2022, filed 10 Feb 2023.